We believe that T2D as a disease is simple, but the situation of patients with T2D is more complicated since most of them have MDS, and T2D is only one of the components that usually occurs later than preobesity, obesity and MASLD
Observed in pilot human work A 2025 IV infusion pilot of BPC-157 in two adults at 10 mg and 20 mg reported no adverse effects on cardiac, hepatic, renal, thyroid, or glucose biomarkers (Lee et al., Alternative Therapies in Health and Medicine, 2025)
That, in turn, can increase the chances of pregnancy
[5] Lee E, Padgett B
Lenny Macrina: Right, and they talk about swelling, joint pain, anxiety, panic attacks, heart palpitations, insomnia, drowsiness, weakness, fatigue, loss of appetite, depression, anhedonia
IGF-1 LR3 is not approved by the FDA for general medical use